LoginSignup
EXACT Sci logo

EXACT Sci

Stock
Stock
ISIN: US30063P1057
Ticker: EXAS
US30063P1057
EXAS

Price

Price

Frequently asked questions

What is EXACT Sci's market capitalization?

The market capitalization of EXACT Sci is $9.82B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for EXACT Sci?

EXACT Sci's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.172. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for EXACT Sci's stock?

Currently, 22 analysts cover EXACT Sci's stock, with a consensus target price of $85.00. Analyst ratings provide insights into the stock's expected performance.

What is EXACT Sci's revenue over the trailing twelve months?

Over the trailing twelve months, EXACT Sci reported a revenue of $2.69B.

What is the EBITDA for EXACT Sci?

EXACT Sci's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $6.96M. EBITDA measures the company's overall financial performance.

What is the free cash flow of EXACT Sci?

EXACT Sci has a free cash flow of $52.93M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of EXACT Sci's stock?

The 5-year beta for EXACT Sci is 1.23. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does EXACT Sci have, and what sector and industry does it belong to?

EXACT Sci employs approximately 6,500 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of EXACT Sci's shares?

The free float of EXACT Sci is 183.08M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $9.82B

5Y beta

 1.23

EPS (TTM)

 -$1.172

Free Float

 183.08M

Revenue (TTM)

 $2.69B

EBITDA (TTM)

 $6.96M

Free Cashflow (TTM)

 $52.93M

Pricing

1D span
$52.41$54.25
52W span
$40.62$79.62

Analyst Ratings

The price target is $85.00 and the stock is covered by 22 analysts.

Buy

20

Hold

2

Sell

0

Information

Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Company’s products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, and OncoExTra Test. The Company’s flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.

6,500

Biotechnology & Drugs

Health Care

Identifier

ISIN

US30063P1057

Primary Ticker

EXAS

Knockouts

Join the conversation
Sign upLogin